About Advanced Clinical Research Private Limited
Data last updated:
Advanced Clinical Research Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 26 March 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51397KA2004PTC033641. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Preeti Lodha and Sreetama Kar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.1156 1st Floor 26th Main 4th 'T' Block Jayanagar, Bengaluru, Karnataka, India – 560041.
The company is associated with 1 brand: Advanced Clinical Research.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website advancedcr.net.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressNo.1156 1st Floor 26th Main 4th 'T' Block Jayanagar, Bengaluru, Karnataka, India – 560041
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands
Advanced Clinical Research operates one associated brand: Advanced Clinical Research. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Operates as a dedicated research site for conducting clinical trials. | advancedcr.net |
Financials of Advanced Clinical Research Private Limited
FY 2025 filings availableAdvanced Clinical Research Private Limited reported revenue of ₹5,000 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 53% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | •••• | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | •••• | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | •••• | |
| Net Profit Margin | •••• | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Advanced Clinical Research are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Board of Directors of Advanced Clinical Research Private Limited
Advanced Clinical Research has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Preeti Lodha | Director | 26 Feb 2021 | 5 Years 7 Months | Current |
| Sreetama Kar | Additional Director | 11 Dec 2023 | 2 Years 10 Months | Current |
Peer Comparison
Advanced Clinical Research Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| JNR PV Solutions India Private Limited | ₹9,003 (FY 2021) | •••• | •••• | -100.0% | •••• | New Delhi, Delhi, India |
| Nano Formulations Private Limited | ₹6,800 (FY 2023) | •••• | •••• | -74.0% | •••• | Bhubaneswar, Odisha, India |
| Advanced Clinical Research Private Limited this company | ₹5,000 (FY 2025) | •••• | •••• | •••• | Bengaluru, Karnataka, India | |
| Vanta Clinical Research Limited | ₹1,983 (FY 2021) | •••• | •••• | -100.0% | •••• | Secunderabad, Telangana, India |
Peers are the companies nearest to Advanced Clinical Research by revenue, above and below it, in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
Advanced Clinical Research Private Limited is audited by M K TYAGI & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M K TYAGI & CO | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Advanced Clinical Research Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Advanced Clinical Research.
: available in the company report
Recent Activity
Advanced Clinical Research Private Limited has 7 board changes on record since 2009: 2 appointments and 5 cessations. The latest: Sreetama Kar was appointed as Additional Director on 11 Dec 2023.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Advanced Clinical Research has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Advanced Clinical Research is an active private limited company based in Bengaluru, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 26 March 2004 (22+ years old) and is registered under CIN U51397KA2004PTC033641.
Advanced Clinical Research has 2 current directors:
- Preeti Lodha - Director
- Sreetama Kar - Additional Director
The latest financial statements of Advanced Clinical Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Advanced Clinical Research has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Advanced Clinical Research is U51397KA2004PTC033641. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Advanced Clinical Research was incorporated on 26 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Advanced Clinical Research by revenue are JNR PV Solutions India Private Limited, Nano Formulations Private Limited, Vanta Clinical Research Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Sreetama Kar was appointed as Additional Director on 11 Dec 2023. Preeti Lodha ceased to be Additional Director on 30 Nov 2021. Mohan Manjunatha Chinny ceased to be Director on 01 Apr 2021. Advanced Clinical Research has 7 board changes on record in total.
Advanced Clinical Research can be reached through the website advancedcr.net. Its registered office is in Bengaluru, Karnataka, India.
The registered office of Advanced Clinical Research is at No.1156 1st Floor 26th Main 4th T Block Jayanagar, Bengaluru, Karnataka, India – 560041.
Advanced Clinical Research operates in the pharma industry, in the pharma contract r and d segment.